$2.52 million grant work to use ACTC ACTcellerate technology

March 2007
Medical Device Daily;3/21/2007, Vol. 11 Issue 54, p3
The article reports on a grant awarded to scientist Randall Lee to fund pre-clinical studies using human embryonic stem cells (HESC) derived from Advanced Cell Technology's proprietary ACTcellerate technology. The research aims to determine if HESC are safe and effective in animal models for heart attacks and heart failure. The funding is for four years of study.


Related Articles

  • The Debate Over: Stem Cells Gets Hot. D'Agnese, Joseph // Discover;Jan2002, Vol. 23 Issue 1, p56 

    Focuses on the controversy over stem cell research in the United States. Advantages in using embryonic stem cells; Funds granted to stem cells research; Sufficiency of embryos in medical treatment. INSETS: NEWS FROM THE WORLD OF ADULT STEM-CELL RESEARCH.;NEWS OF EMBRYONIC STEM CELLS.;A REVERSE...

  • No end in sight for stem-cell odyssey. Cyranoski, David // Nature;2/9/2006, Vol. 439 Issue 7077, p658 

    The article presents developments in the human embryonic stem-cell research of Advanced Cell Technology Corp. in Worcester, Massachusetts. In October 2003, Robert Lanza, vice-president for research says thirteen of sixteen cloned human eggs activated by transfer of a somatic nucleus had...

  • CHOOSE LIFE. Singer, Peter; Sagan, Agata // Bulletin with Newsweek;9/5/2006, Vol. 124 Issue 6536, p36 

    The article focuses on the growing opposition against embryonic stem cell research. The successful development of embryonic stem cells without destroying the embryo by a team of scientists led by Robert Lanza at Massachusetts-based biotechnology firm Advanced Cell Technology Corp., has been...

  • Leading Eye Institute to Participate in ACT's Embryonic Stem Cell Clinical Trial for Macular Degeneration.  // Biomedical Market Newsletter;1/21/2012, Vol. 21, p1 

    The article informs that Advanced Cell Technology Inc., a regenerative medicine provider has announced that its institutional review board (IRB) has approved Wills Eye Institute of Philadelphia as the site for the clinical trial. The trial will be based on dry age-related macular degeneration...

  • The Full Story Behind ACT's Human Embryo Study. Andrusko, Dave // National Right to Life News;Sep2006, Vol. 33 Issue 9, p18 

    The article talks about the study on embryonic stem cells conducted by Advanced Cell Technology Corp. The study recognizes that it would be good for all parties to the debate if embryonic stem cells could be created without destroying human embryos in the process. According to Ronald Green, an...

  • Nature Publishes Amended Stem Cell Study. Townsend, Liz // National Right to Life News;Dec2006, Vol. 33 Issue 12, p11 

    The article reports that scientists at Advanced Cell Technology (ACT), who originally claimed that they could extract embryonic stem cells without killing the embryo have admitted that all embryos used in their experiments were killed. The scientists also clarified parts of their article in an...

  • DESIGNING AN EFFECTIVE PROGRAM OF STATE-SPONSORED HUMAN EMBRYONIC STEM CELL RESEARCH. Noll, Roger G. // Berkeley Technology Law Journal;Summer2006, Vol. 21 Issue 3, p1143 

    The article discusses the methods of establishing an effective program of state-sponsored human embryonic stem cell research as depicted in the creation of the California Institute for Regenerative Medicine. One of the methods is the elimination of "pork barrel" effects on the funding for these...

  • FROM THE LAB.  // Medical Technology & Devices Week;2/26/2007, Vol. 5 Issue 9, p1 

    The article reports on the awarding of the Scientific Excellence through Exploration and Development (SEED) Grants to several human embryonic stem cell (hESC) studies in California. The Independent Citizens Oversight Committee (ICOC), governing board of the California Institute for Regenerative...

  • Stem Cell Suicide. Davies, Kevin // Bio-IT World;Jul2003, Vol. 2 Issue 7, p6 

    Offers updates on the state of embryonic stem cell research despite funding restrictions issued by the U.S. government, as of July 2003. Breakthroughs in the field of embryonic stem cell research; Pledge made by National Institutes of Health Director Elias Zerhouni to help improve stem cell...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics